Back to mobile site

TD Cowen on Medtronic, Inc. (MDT): 'Buy; We Expect Solid F2Q Results'

November 14, 2025 8:57 AM EST Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $106.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login